SCHEMBL6749288

SCHEMBL6749288

NS(=O)(=O)NC1CCN(Cc2ccccc2)CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.65
KMT2A Q03164 6/20 0.60
MEN1 O00255 2/20 0.60
ALDH1A1 P00352 2/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
THRB P10828 1/20 0.60
BCHE P06276 2/20 0.59
ACHE P22303 2/20 0.59
BACE1 P56817 2/20 0.59
SIGMAR1 Q99720 4/20 0.57
HTR2A P28223 1/20 0.56
OPRK1 P41145 1/20 0.56
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C19 P33261 1/20 0.55
RECQL P46063 1/20 0.55
DRD4 P21917 2/20 0.53
DRD2 P14416 1/20 0.53
DRD3 P35462 1/20 0.53
MAPT P10636 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6335815 0.86 HTT (0.67) HTTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL6752179 0.85 HTT (0.65) HTTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL6749008 0.85 HTT (0.65) HTTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL6965515 0.84 HTT (0.85) HTTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL13102870 0.81 HTT (0.61) HTTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL3961060 0.81 HTT (0.64) HTTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL13102942 0.80 HTT (0.60) HTTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL2098424 0.80 ALDH1A1 (0.70) HTTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL27773273 0.80 HTR2A (0.69) HTTKMT2AMEN1SMN1; SMN2BCHE
SCHEMBL2886054 0.79 HTT (0.58) HTTKMT2AMEN1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040092737-A1 Benzopiperidine derivatives EISAI CO., LTD. 2004-05-13 US disclosed
US-6518423-B1 These compounds are useful as drugs efficacious in the prevention and treatment of these various inflammatory diseases and immunologic diseases, such as rheumatoid arthritis, atopic dermatitis, psoriasis, asthma, and EISAI CO., LTD. (JP) 2003-02-11 US disclosed
EP-0934941-A1 BENZOPIPERIDINE DERIVATIVES Eisai Co., Ltd. (JP) 1999-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092737-A1 Benzopiperidine derivatives HLA-DRB1, HRH1, HRH2 HTT 2395/4885KMT2A 3395/4885MEN1 4580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.